PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Pediatrics, University of Florida Diabetes Institute, College of Medicine, Gainesville, FL hallemj@peds.ufl.edu.\', \'Department of Pediatrics, University of Florida Diabetes Institute, College of Medicine, Gainesville, FL.\', \'Department of Pathology, Immunology and Laboratory Medicine, University of Florida Diabetes Institute, College of Medicine, Gainesville, FL.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.2337/dbi20-0045
?:hasPublicationType
?:journal
  • Diabetes
is ?:pmid of
?:pmid
?:pmid
  • 33632743
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 4.435
?:rankingScore_hIndex
  • 297
is ?:relation_isRelatedTo_publication of
?:title
  • How Do We Move Type 1 Diabetes Immunotherapies Forward During the Current COVID-19 Pandemic?
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all